Evidence map›Paper›PMID 36178345›Full record

ArticleeLife2022

Evolution of cell size control is canalized towards adders or sizers by cell cycle structure and selective pressures.

Felix Proulx-Giraldeau, Jan M Skotheim, Paul François

Abstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Identification of the Down Syndrome Critical Region 3 Gene as a Mammalian Cell Size Regulator.Genes to cells : devoted to molecular & cellular mechanisms · 2026
    Article
  2. Article
  3. Evolutionary Advantage of Cell Size Control.Physical review letters · 2025
    Article
  4. Review
  5. Proliferation symmetry breaking in growing tissues.bioRxiv : the preprint server for biology · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Felix Proulx-GiraldeauDepartment of Physics, McGill University, Montreal, Canada.ORCID 0000-0003-0238-5410
Jan M SkotheimDepartment of Biology, Stanford University, Stanford, United States.
Paul FrançoisDepartment of Physics, McGill University, Montreal, Canada.ORCID 0000-0002-2223-839X

Funding

Determining how cell growth triggers cell divisionR35GM134858 · NIGMS · STANFORD UNIVERSITY · PI Jan M Skotheim · 2020 to 2026
$4.1M
NIGMS NIH HHS R35 GM134858
6 · The paper itself

Abstract

Cell size is controlled to be within a specific range to support physiological function. To control their size, cells use diverse mechanisms ranging from 'sizers', in which differences in cell size are compensated for in a single cell division cycle, to 'adders', in which a constant amount of cell growth occurs in each cell cycle. This diversity raises the question why a particular cell would implement one rather than another mechanism? To address this question, we performed a series of simulations evolving cell size control networks. The size control mechanism that evolved was influenced by both cell cycle structure and specific selection pressures. Moreover, evolved networks recapitulated known size control properties of naturally occurring networks. If the mechanism is based on a G1 size control and an S/G2/M timer, as found for budding yeast and some human cells, adders likely evolve. But, if the G1 phase is significantly longer than the S/G2/M phase, as is often the case in mammalian cells in vivo, sizers become more likely. Sizers also evolve when the cell cycle structure is inverted so that G1 is a timer, while S/G2/M performs size control, as is the case for the fission yeast

Indexed as

Models, BiologicalSchizosaccharomycesAnimalsCell CycleCell DivisionCell SizeHumansMammalscell cyclechlamydomonaschlamydomonas reinhardtiicomputational biologygene networksmathematical modellingS. cerevisiaeS. pombesystems biology

Identifiers

PMID36178345
PMCPMC9651955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.